11/20/2024
7:47 AM | H LUNDBECK A S (Filed by)
Longboard Pharmaceuticals (Subject)
| Form SC TO-T/A | |
11/20/2024
7:01 AM | Longboard Pharmaceuticals (Subject)
| Form SC 14D9/A | |
11/19/2024
7:13 PM | Kaye Randall (Reporting)
Longboard Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/15/2024
5:18 AM | H LUNDBECK A S (Filed by)
Longboard Pharmaceuticals (Subject)
| Form SC TO-T/A | |
11/14/2024
2:10 PM | Cormorant Asset Management, LP (Filed by)
Longboard Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/13/2024
7:48 PM | Lind Kevin Robert (Reporting)
Longboard Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2024
8:26 AM | FMR LLC (Filed by)
Longboard Pharmaceuticals (Subject)
| Form SC 13G/A | |
|
11/07/2024
8:12 AM | FMR LLC (Filed by)
Longboard Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/06/2024
7:56 AM | H LUNDBECK A S (Filed by)
Longboard Pharmaceuticals (Subject)
| Form SC TO-T/A | |
11/06/2024
5:06 AM | Longboard Pharmaceuticals (Subject)
| Form SC 14D9/A | |
11/04/2024
12:25 PM | Longboard Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
10/30/2024
7:57 AM | Longboard Pharmaceuticals (Subject)
| Form SC 14D9 | |
10/30/2024
6:40 AM | H LUNDBECK A S (Filed by)
Longboard Pharmaceuticals (Subject)
| Form SC TO-T | |
10/29/2024
3:38 PM | Lind Kevin Robert (Reporting)
Longboard Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/29/2024
3:40 PM | Longboard Pharmaceuticals (Issuer)
Roberts Brandi (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/29/2024
3:43 PM | Kaye Randall (Reporting)
Longboard Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/25/2024
4:18 PM | H LUNDBECK A S (Filed by)
Longboard Pharmaceuticals (Subject)
| Form SC TO-C | |
10/22/2024
2:24 PM | BlackRock, Inc. (Filed by)
Longboard Pharmaceuticals (Subject)
| Form SC 13G | |
10/16/2024
4:16 PM | H LUNDBECK A S (Filed by)
Longboard Pharmaceuticals (Subject)
| Form SC TO-C | |
10/16/2024
3:40 PM | Kaye Randall (Reporting)
Longboard Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2024
8:39 PM | Longboard Pharmaceuticals (Subject)
| Form SC14D9C | |
10/15/2024
4:08 PM | H LUNDBECK A S (Filed by)
Longboard Pharmaceuticals (Subject)
| Form SC TO-C | |
10/15/2024
9:22 AM | H LUNDBECK A S (Filed by)
Longboard Pharmaceuticals (Subject)
| Form SC TO-C | |
10/15/2024
5:20 AM | Longboard Pharmaceuticals (Subject)
| Form SC14D9C | |
10/15/2024
5:14 AM | Longboard Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/16/2024
6:36 PM | Kaye Randall (Reporting)
Longboard Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
3:35 PM | Kaye Randall (Reporting)
Longboard Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/13/2024
5:01 PM | Kaye Randall (Reporting)
Longboard Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2024
5:03 PM | Lind Kevin Robert (Reporting)
Longboard Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
3:12 PM | Kaye Randall (Reporting)
Longboard Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/01/2024
3:20 PM | Longboard Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/15/2024
3:17 PM | Longboard Pharmaceuticals (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
| Form SC 13G | |
07/01/2024
8:15 AM | Longboard Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/10/2024
8:05 AM | Longboard Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/24/2024
3:05 PM | Longboard Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/02/2024
3:15 PM | Longboard Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/15/2024
8:16 AM | Longboard Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/12/2024
3:21 PM | Longboard Pharmaceuticals (Filer)
| Form ARS | |
04/12/2024
3:16 PM | Longboard Pharmaceuticals (Filer)
| Form DEFA14A | |
03/26/2024
4:25 PM | Longboard Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/12/2024
3:45 PM | Longboard Pharmaceuticals (Filer)
| Form S-3ASR | |
917 Trades… Zero Losses? (Ad) As you likely know, the “Trump bump” launched stocks to record highs after he secured his second reelection bid.
Now, Trump and his team are coming to gut government regulation – and it’s going to create some incredible market opportunities.
But while the masses chase large-cap tech and so-called AI stocks, a small circle of traders are using a strange but tactical method to find a pool of “hidden Trump trades.” Go here to see how you can start accessing these opportunities today |
03/12/2024
3:15 PM | Longboard Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/11/2024
7:19 AM | FMR LLC (Filed by)
Longboard Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/14/2024
5:03 AM | Longboard Pharmaceuticals (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SC 13G/A | |
02/13/2024
8:55 AM | Longboard Pharmaceuticals (Subject)
Prosight Management, LP (Filed by)
| Form SC 13G/A | |
01/30/2024
10:23 AM | Farallon Capital Partners, L.P. (Filed by)
Longboard Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/29/2024
3:37 PM | ARENA PHARMACEUTICALS INC (Reporting)
Longboard Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2024
3:12 PM | Longboard Pharmaceuticals (Subject)
PFIZER INC (Filed by)
| Form SC 13D/A | |
01/04/2024
3:51 PM | Longboard Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2024
3:48 PM | Longboard Pharmaceuticals (Filer)
| Form 424B5 | |
01/03/2024
7:59 PM | Longboard Pharmaceuticals (Filer)
| Form S-3MEF | |
01/02/2024
3:54 PM | Longboard Pharmaceuticals (Filer)
| Form 424B5 | |
01/02/2024
8:44 AM | Longboard Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/29/2023
7:35 AM | Longboard Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
